Protein Expression and Genomic Alterations of PMS2 in Urothelial Bladder Cancer

被引：0
|
作者：
Nozad, Sahar
Shiekhmohammed, Mohammed
Kallakury, Bhaskar V. S.
Sheehan, Christine E.
Elvin, Julia A.
Vergilio, Jo-Anne
Suh, James
Ramkissoon, Shakti H.
Ali, Siraj M.
Schrock, Alexa
Pal, Sumanta
Fisher, Hugh A.
Mian, Badar
Nazeer, Tipu
Fabrizio, David
Frampton, Garrett
Connelly, Caitlin
Miller, Vincent
Stephens, Philip
Gay, Laurie M.
Ross, Jeffrey
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Georgetown Univ Hosp, Washington, DC 20007 USA
[3] Fdn Med, Cambridge, MA USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
994
引用
收藏
页码：246A / 246A
页数：1
相关论文
共 50 条
  • [31] Bladder cancer subtypes defined by genomic alterations
    Knowles, Margaret A.
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2008, 42 : 116 - 130
  • [32] Genomic Alterations of Mexican Patients with Bladder Cancer
    Perez Montiel, Maria Delia
    Cerrato Izaguirre, Dennis
    Cortes, Carlo
    Diaz-Chavez, Jose
    Angel Jimenez, Miguel
    Scavuzzo, Anna
    Orozco, Alicia
    Ramirez, Andrea
    Rubio, Jairo
    Sanchez Perez, Yessenia
    Herrera, Luis
    Cantu de Leon, David
    Prada, Diddier
    LABORATORY INVESTIGATION, 2023, 103 (03) : S788 - S789
  • [33] PMS2 amplification contributes brain metastasis from lung cancer
    Chen, Jianing
    Hu, Congli
    Yang, Hainan
    Wang, Li
    Chu, Xiangling
    Yu, Xin
    Zhang, Shiji
    Li, Xuefei
    Zhao, Chao
    Cheng, Lei
    Hong, Weiping
    Liu, Da
    Wen, Lei
    Su, Chunxia
    BIOLOGICAL PROCEDURES ONLINE, 2024, 26 (01)
  • [34] Detection of Germline PMS2 mutation in Japanese colorectal cancer patients
    Sugano, Kokichi
    Nakajima, Takeshi
    Takatsu, Mizuki
    Sekine, Shigeki
    Saito, Shinya
    Imai, Kazuho
    Takai, Kyouko
    Ushiama, Mineko
    Sakamoto, Hiromi
    Yoshida, Teruhiko
    CANCER SCIENCE, 2018, 109 : 862 - 862
  • [35] MLH1 and PMS2 Define Prognosis in Sporadic Urothelial Carcinoma of Renal Pelvis and Ureter
    Andres, L.
    Zaldumbide, L.
    Gaafar, A.
    Gonzalez, J.
    Tello, A. Garcia
    Angulo, J. C.
    Lopez, J. I.
    LABORATORY INVESTIGATION, 2011, 91 : 177A - 177A
  • [36] A Missed Case of Lynch Syndrome with PMS2 Loss of Expression at Extreme Age
    Bhatta, Prajjwol
    Arutla, Venkat
    Warraich, Fatima
    Syed, Tausif
    Niu, Chengu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2090 - S2090
  • [37] PMS2: a potential prognostic protein marker in oral squamous cell carcinoma
    Lira Decker, Jordana Medeiros
    de Oliveira Filho, Osias Vieira
    Freitas, Milena Oliveira
    de Lima Silva-Fernandes, Isabelle Joyce
    Dantas, Thinali Sousa
    de Paula Campelo, Clarissa Sales
    Socorro Saldanha Cunha, Maria do Perpetuo
    de Barros Silva, Paulo Goberlanio
    Sousa, Fabricio Bitu
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2021, 26 (04): : E451 - E458
  • [38] Interaction site of the mismatch repair protein PMS2 with the proapoptotic protein p73
    Shimodaira, Hideki
    Takahashi, Masanobu
    Ishioka, Chikashi
    CANCER RESEARCH, 2006, 66 (08)
  • [39] Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency
    Vasovcak, P.
    Krepelova, A.
    Menigatti, M.
    Puchmajerova, A.
    Skapa, P.
    Augustinakova, A.
    Amann, G.
    Wernstedt, A.
    Jiricny, J.
    Marra, G.
    Wimmer, K.
    DNA REPAIR, 2012, 11 (07) : 616 - 623
  • [40] Epigenetic alterations in urothelial bladder cancer associated with disease outcomes
    Nunes, Francisca Martins
    Apolonio, Joana Dias
    Mota-Pinto, Anabela
    Leao, Ricardo
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (03) : 220 - 229
12345